RNA-seq analysis conducted by Veeraraghavan and colleagues on 990 primary TCGA breast samples identified the first ESR1 gene fusion, ESR1-e2>CCDC170 (Table 1), in a subset (2.1%) of Luminal B breast tumor samples (75, 82). Here, ESR1 is linked to breast neoplasm.